These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2555 related articles for article (PubMed ID: 34784980)

  • 1. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-
    Zhao Z; Li F; Ning J; Peng R; Shang J; Liu H; Shang M; Bao XQ; Zhang D
    Acta Pharm Sin B; 2021 Sep; 11(9):2859-2879. PubMed ID: 34589401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
    Ma XZ; Chen LL; Qu L; Li H; Wang J; Song N; Xie JX
    Acta Pharmacol Sin; 2024 Jan; 45(1):52-65. PubMed ID: 37674043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
    Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
    Gui J; Sun X; Wen S; Liu X; Qin B; Sang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):270-279. PubMed ID: 38501412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein.
    Zhong Z; Chen W; Gao H; Che N; Xu M; Yang L; Zhang Y; Ye M
    Neurochem Res; 2021 Nov; 46(11):3050-3058. PubMed ID: 34347266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigation of maternal fecal microbiota transplantation on neurobehavioral deficits of offspring rats prenatally exposed to arsenic: Role of microbiota-gut-brain axis.
    Zhao Q; Hao Y; Yang X; Mao J; Tian F; Gao Y; Tian X; Yan X; Qiu Y
    J Hazard Mater; 2023 Sep; 457():131816. PubMed ID: 37307732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.
    Perez-Pardo P; Dodiya HB; Engen PA; Forsyth CB; Huschens AM; Shaikh M; Voigt RM; Naqib A; Green SJ; Kordower JH; Shannon KM; Garssen J; Kraneveld AD; Keshavarzian A
    Gut; 2019 May; 68(5):829-843. PubMed ID: 30554160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson's disease: An animal study.
    Yan Z; Yang F; Sun L; Yu J; Sun L; Si Y; Yao L
    Brain Behav Immun; 2022 Nov; 106():307-321. PubMed ID: 36126853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
    Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
    Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease.
    Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC
    Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.
    Wang N; Feng BN; Hu B; Cheng YL; Guo YH; Qian H
    Food Funct; 2022 Feb; 13(4):2019-2032. PubMed ID: 35103734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease.
    Fang X; Liu S; Muhammad B; Zheng M; Ge X; Xu Y; Kan S; Zhang Y; Yu Y; Zheng K; Geng D; Liu CF
    Neural Regen Res; 2024 Sep; 19(9):2081-2088. PubMed ID: 38227539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis.
    Jing Y; Yu Y; Bai F; Wang L; Yang D; Zhang C; Qin C; Yang M; Zhang D; Zhu Y; Li J; Chen Z
    Microbiome; 2021 Mar; 9(1):59. PubMed ID: 33678185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
    Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 128.